Richard D Goold from 2618 Belmont Canyon Rd, Belmont, CA 94002, age 64, Phone: 6507997586

Name / Title

Company / Classification

Phones & Addresses

Richard D. Goold
President

Station X
Biotechnology

185 Berry St SUITE 5503, San Francisco, CA 94107
2475 Hanover St, Palo Alto, CA 94304
301 Chesapeake Dr, Redwood City, CA 94063

Richard D. Goold
Chief Executive Officer

X Station Inc
Custom Computer Programing

185 Berry St, San Francisco, CA 94107
301 Chesapeake Dr, Redwood City, CA 94063

Resumes

South San Francisco, California

view source

Location:

South San Francisco, CA

Industry:

Biotechnology

Work:

Lyell Immunopharma
Chief Information Officer
Lyell Immunopharma Dec 2018 - Apr 2019
Svp, Information Sciences
Station X 2010 - 2018
Founder and Chief Executive Officer
Incyte 2002 - 2004
Svp, Chief Genomics Officer
Prospect Genomics 2000 - 2002
Founder and President

Education:

University of Cape Town 1984 - 1989
Doctorates, Doctor of Philosophy, Biochemistry Rhodes University 1983 - 1984
Rhodes University 1980

Skills:

Genomics
Bioinformatics
Biotechnology
Drug Discovery
Molecular Biology
Genetics
Life Sciences
Lifesciences
Computational Biology
Sequencing
Dna Sequencing
Biochemistry
Cancer
Personalized Medicine
Dna
Biomarkers
Commercialization
Oncology
Biopharmaceuticals
Systems Biology
Immunology
Cell
Biomarker Discovery

Richard Goold

view source

Us Patents

System And Method For A Precompiled Database For Biomolecular Sequence Information
view source
US Patent:

6389428, May 14, 2002
Filed:

Apr 11, 2001
Appl. No.:

09/797653
Inventors:

Philippe E. Rigault - Palo Alto CA
Anne L. Curtis - Pacifica CA
Richard D. Goold - Belmont CA
David A. Hadley - Palo Alto CA
Harold H. Hibbert - Fremont CA
Tod M. Klingler - San Carlos CA
Robert E. Lagace - San Francisco CA
Laura L. Stuve - Los Gatos CA
Michael G. Walker - Sunnyvale CA
Michael P. Wood - San Francisco CA
Assignee:

Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:

G06F 1730
US Classification:

7071041, 707 6, 707100, 702 19, 435 6
Abstract:

A computer system stores biomolecular data in a database in a memory. The biomolecular database has a set of entities. Each entity stores attributes for a plurality of entries. At least one attribute is stored in an array. Data associated with an entry is stored at a location in the array. An entity offset designates the location of the data in the array. The same entity offset value is used to access data associated with a particular entry for all attributes within the entity.

Database For Storage And Analysis Of Full-Length Sequences
view source
US Patent:

20020064792, May 30, 2002
Filed:

Sep 19, 2001
Appl. No.:

09/956999
Inventors:

Stephen Lincoln - Redwood City CA, US
Tod Klingler - San Carlos CA, US
Janice Au-Young - Berkeley CA, US
Y. Tang - San Jose CA, US
Richard Goold - San Francisco CA, US
Ingrid Akerblom - Redwood City CA, US
Jeffrey Seilhamer - Los Altos Hills CA, US
Phillip Hawkins - Mountain View CA, US
Lynn Murry - Portola Valley CA, US
Angelo Delegeane - Milipitas CA, US
Wendy Levine - Mountain View CA, US
Jennifer Hillman - Mountain View CA, US
Surya Goli - San Jose CA, US
Christina Altus - Palo Alto CA, US
Olga Bandman - Mountain View CA, US
Samuel LaBrie - O'Fallon MO, US
Purvi Shah - Sunnyvale CA, US
International Classification:

C12Q001/68
G06F019/00
G01N033/48
G01N033/50
US Classification:

435/006000, 702/020000
Abstract:

The present invention is a computerized storage and retrieval system for genetic information and related annotated information. The data of the system is stored in a relational database which interfaces with public databases to allow analysis both within the database of the invention and between information within that database and external public databases. The sequence data is edited before entry into the system, and is stored in a curated, functional clustering organization. The information associated with the data is stored in an expression database that is linked to the storage of the sequence data.

Tumor Suppressor
view source
US Patent:

20020146712, Oct 10, 2002
Filed:

Aug 7, 2001
Appl. No.:

09/924654
Inventors:

Richard Goold - Belmont CA, US
Ingrid Akerblom - Redwood City CA, US
Jeffrey Seilhamer - Los Altos Hills CA, US
Roger Coleman - Mountain View CA, US
International Classification:

C12Q001/68
G01N033/53
C12P021/04
C07K016/28
C07K014/705
US Classification:

435/006000, 435/007100, 435/070210, 530/388220, 530/350000
Abstract:

The invention provides a cDNA which encodes a tumor suppressor. It also provides for the use of the cDNA, protein, and antibody in the diagnosis, prognosis, treatment and evaluation of therapies for cancer. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.

Database For Storage And Analysis Of Full-Length Sequences
view source
US Patent:

6303297, Oct 16, 2001
Filed:

Nov 13, 1997
Appl. No.:

8/969987
Inventors:

Steve E. Lincoln - Redwood City CA
Tod M. Klingler - San Carlos CA
Janice Au-Young - Berkeley CA
Y. Tom Tang - San Jose CA
Richard D. Goold - San Francisco CA
Ingrid E. Akerblom - Redwood City CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Phillip R. Hawkins - Mountain View CA
Lynn E. Murry - Portola Valley CA
Angelo M. Delegeane - Milpitas CA
Wendy B. Levine - Mountain View CA
Jennifer L. Hillman - Mountain View CA
Surya K. Goli - San Jose CA
Christina M. Altus - Palo Alto CA
Olga Bandman - Mountain View CA
Samuel T. LaBrie - O'Fallon MO
Purvi Shah - Sunnyvale CA
Assignee:

Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:

C12Q 168
US Classification:

435 6
Abstract:

The present invention is a computerized storage and retrieval system for genetic information and related annotated information. The data of the system is stored in a relational database which interfaces with public databases to allow analysis both within the database of the invention and between information within that database and external public databases. The sequence data is edited before entry into the system, and is stored in a curated, functional clustering organization. The information associated with the data is stored in an expression database that is linked to the storage of the sequence data.

Polynucleotides Panc1A And Panc1B Associated With Pancreatic Cancer
view source
US Patent:

58408703, Nov 24, 1998
Filed:

Dec 29, 1995
Appl. No.:

8/581240
Inventors:

Richard D. Goold - San Francisco CA
Ingrid E. Akerblom - Redwood City CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Assignee:

Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:

C12N 1511
C12N 1566
C12N 1585
C07H 2104
US Classification:

536 235
Abstract:

The present invention provides polynucleotide sequences designated PANC1A and PANC1B which are associated with a genomic sequence related to pancreatic cancer as well as other cancers. The present invention also provides for PANC1A and PANC1B antisense molecules. The invention further provides genetically engineered expression vectors and host cells for the production of purified PANC1A and PANC1B polypeptide; antibodies, antagonists and inhibitors of PANC1A and PANC1B polypeptide; and pharmaceutical compositions and methods of treatment based on the polypeptide, its antibodies, antagonists and inhibitors. The invention specifically provides for use of the polypeptide as a diagnostic composition for the detection of pancreatic cancer in individuals at risk for and subject to pancreatic cancer. The invention also relates to therapeutic methods and compositions based upon the nucleotide sequences for PANC1A and PANC1B.

System And Method For A Precompiled Database For Biomolecular Sequence Information
view source
US Patent:

62231863, Apr 24, 2001
Filed:

Oct 20, 1998
Appl. No.:

9/175738
Inventors:

Philippe E. Rigault - Palo Alto CA
Anne L. Curtis - Pacifica CA
Richard D. Goold - Belmont CA
David A. Hadley - Palo Alto CA
Harold H. Hibbert - Fremont CA
Tod M. Klingler - San Carlos CA
Robert E. Lagace - San Francisco CA
Laura L. Stuve - Los Gatos CA
Michael G. Walker - Sunnyvale CA
Michael P. Wood - San Francisco CA
Assignee:

Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:

G06F 1730
US Classification:

707104
Abstract:

A computer system stores biomolecular data in a database in a memory. The biomolecular database has a set of entities. Each entity stores attributes for a plurality of entries. At least one attribute is stored in an array. Data associated with an entry is stored at a location in the array. An entity offset designates the location of the data in the array. The same entity offset value is used to access data associated with a particular entry for all attributes within the entity.

Polynucleotides Encoding A Protein Associated With Pancreatic Cancer
view source
US Patent:

59981652, Dec 7, 1999
Filed:

Mar 15, 1996
Appl. No.:

8/616392
Inventors:

Richard D. Goold - San Francisco CA
Ingrid E. Akerblom - Redwood City CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Roger Coleman - Mountain View CA
Assignee:

Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:

C12N 1512
US Classification:

435 691
Abstract:

The present invention provides polynucleotides and related reagents which are associated with pancreatic and other cancers. These polynucleotides are designated PANC1A.

Dna Encoding A Pac10 Human Homolog
view source
US Patent:

63098210, Oct 30, 2001
Filed:

May 16, 1996
Appl. No.:

8/648736
Inventors:

Janice Au-Young - Berkley CA
Richard D. Goold - San Francisco CA
Assignee:

Incyte Genomics, Inc. - Palo Alto CA
International Classification:

C12Q 168
C12P 1934
US Classification:

435 6
Abstract:

The present invention provides nucleotide and amino acid sequences for a novel PAC10 human homolog. The present invention also provides for antisense molecules, diagnostic molecules, genetically engineered expression vectors and host cells for the production of purified PAC10 homologs; antibodies, agonists, antagonists and inhibitors of the PAC10 human homolog; and pharmaceutical compositions and methods of treatment based on the polypeptide, its antibodies, ntagonists and inhibitors. The invention further provides diagnostic and theapeutic compositions for the detection and treatment of X-linked congenital abnormalities, such as centronuclear myopathy.